| Value | ₹1,999 Cr |
|---|
BSE filing, NSE: SOBHA. Summary written from the filing by ALFA Finder's alert engine.
Sobha Ltd: key numbers
- Share price
- ₹1,125.10
- Market cap
- ₹12,032 Cr
- Revenue (annual)
- ₹5,190 Cr
- Net profit (annual)
- ₹193.4 Cr
- P/E (TTM)
- 63.0×Sector 34.5×
- Promoter holding
- 52.89%+0.01% QoQ
- FII holding
- 6.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sobha Ltd
All →Sobha Capital Structure Change
Bandhan Mutual Fund, a non-promoter, acquired 2,183,115 Sobha Ltd shares through the secondary market. Its stake rose from 7.03% to 9.07% of paid-up equity capital.
Sobha Legal & Regulatory
Sobha faces a GST order for Rs 29.76 Crore tax plus interest and penalty, and is appealing to GSTAT. The company reports no operational impact.
- Value
- ₹29.76 Cr
Sobha Earnings Call Transcript: Key Takeaways
Sobha delivered record H1 pre-sales despite Q2 margin compression. Management is banking on a heavy H2 launch pipeline and high-margin new inventory to restore profitability.
- Call
- Guides 50% growth
Sobha Capital Structure Change
Sobha Limited issued a final notice for payment of the first and final call of ₹825.50 per partly paid-up share on 20,857 shares outstanding.
- Value
- ₹1.72 Cr
Sobha Acquisition Worth ₹12.7 Cr
Sobha Limited will acquire the fire and safety business division of Sobha Projects and Trade Private Limited in a slump sale for ₹12.70 Crore.
- Value
- ₹12.70 Cr
- Execution
- Three months
Sobha Merger & Restructuring Worth ₹12.7 Cr
Sobha Limited is acquiring the fire and safety division of Sobha Projects and Trade Private Limited via a slump sale for Rs. 12.7 Crore.
- Value
- ₹12.70 Cr
- Execution
- Three months
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr